Literature DB >> 29662140

Association between heart failure with preserved ejection fraction and hypertensive retinopathy: more questions than answers!

Sunil K Nadar1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29662140     DOI： 10.1038/s41371-017-0022-1

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  17 in total

1.  Assessment of left atrium and diastolic dysfunction in patients with hypertensive retinopathy: A real-time three-dimensional echocardiography-based study.

Authors:  Batur Gonenc Kanar; Hatice Selen Kanar; Aysu Karatay; Kursat Tigen; Ayse Sonmez
Journal:  Clin Exp Hypertens       Date:  2017-07-31       Impact factor: 1.749

2.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

3.  Spironolactone for heart failure with preserved ejection fraction.

Authors:  Bertram Pitt; Marc A Pfeffer; Susan F Assmann; Robin Boineau; Inder S Anand; Brian Claggett; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Brian Harty; John F Heitner; Christopher T Kenwood; Eldrin F Lewis; Eileen O'Meara; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Song Yang; Sonja M McKinlay
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

Review 4.  Hypertension and the eye: changing perspectives.

Authors:  S Chatterjee; S Chattopadhyay; M Hope-Ross; P L Lip; S Chattopadhya
Journal:  J Hum Hypertens       Date:  2002-10       Impact factor: 3.012

Review 5.  Treatment of heart failure with normal ejection fraction: an inconvenient truth!

Authors:  Walter J Paulus; Joris J M van Ballegoij
Journal:  J Am Coll Cardiol       Date:  2010-02-09       Impact factor: 24.094

6.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; Bruce B Duncan; David J Couper; James M Tielsch; Barbara E K Klein; Larry D Hubbard
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

7.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

8.  Hypertensive retinopathy and incident coronary heart disease in high risk men.

Authors:  B B Duncan; T Y Wong; H A Tyroler; C E Davis; F D Fuchs
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 9.  Epidemiology of heart failure with preserved ejection fraction.

Authors:  Charlotte Andersson; Ramachandran S Vasan
Journal:  Heart Fail Clin       Date:  2014-07       Impact factor: 3.179

10.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.